Clinical Scale Expansion Project
A conversion completed in less than nine months, the upgraded facility is now home to mRNA clinical manufacturing, plasmid manufacturing, Personalized Vaccine Units manufacturing, pre-clinical labs, QC labs, development labs, warehouse/logistics and maintenance, and plant utilities, as well as all necessary office, amenity, and administration areas. This cGMP clinical manufacturing facility is where the first COVID vaccines were produced.
Science & Technology
DPS Global, TRIA
Office, Occupied Renovation, Laboratory, Cleanroom, cGMP, Building Conversion
Aggressive timeline to get the critical facility up and operational
Lean construction practices and comprehensive workflow
COVID vaccine production was able to take place at a critical time during the pandemic thanks to finishing the facility ahead of schedule and under budget
How Can We Help?